
Trevi Therapeutics Gehälter & Vergütung
Biotechnology Research
Trevi Therapeutics is a profoundly innovative, fiercely dedicated clinical-stage biopharmaceutical company absolutely pioneering highly advanced neurology treatments. They brilliantly develop incredibly targeted therapies—including their absolute breakthrough oral nalbuphine extended-release (Haduvio)—fiercely aiming to completely eradicate incredibly severe chronic cough and debilitating pruritus, profoundly transforming deeply critical patient quality of life.
Hauptsitz:New Haven, United States
Gegründet:2011
Mitarbeiter:1-50
Typ:public
Geschätzter Umsatz:$0-$1M
Hauptsitz
Noch keine Gehaltsdaten für Trevi Therapeutics.
Als Erster einreichen